Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Satellos Bioscience Inc. (MSCLF) had Return on Tangible Equity of -14.74% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.14M |
|
-- |
|
-- |
|
$6.48M |
|
$-6.48M |
|
$0.40M |
|
$-6.08M |
|
$-6.08M |
|
$-6.14M |
|
$-6.14M |
|
$-6.14M |
|
$-6.14M |
|
$-6.48M |
|
$-6.48M |
|
165.82M |
|
165.82M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$44.37M |
|
$0.00M |
|
$0.00M |
|
$44.37M |
|
$2.70M |
|
-- |
|
-- |
|
$2.70M |
|
$41.67M |
|
$41.67M |
|
$41.67M |
|
165.82M |
|
| Cash Flow Statement Financials | |
$-7.37M |
|
-- |
|
$0.00M |
|
$40.07M |
|
$32.71M |
|
$-7.36M |
|
$0.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.74% |
|
|
Return on Tangible Equity |
-14.74% |
-13.84% |
|
-14.74% |
|
$0.25 |
|
$-0.04 |
|
$-0.04 |
|